Internal Medicine, Hematology · Rochester, MN
NPI
1780067314
Since 2015
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$294K
19,019 services
Medicare patients, 2024
213
Average age 73
Drug cost, 2024
$2.1M
555 prescriptions
Company payments, 2025
$2,300
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Antoine N Saliba was code J0248 (injection, remdesivir, 1 mg), 2,700 times for 14 patients. In total Antoine N Saliba billed 19,019 services in 51 codes, and Medicare paid $294K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0248 Injection, remdesivir, 1 mg | Office | 2,700 | 14 | $4.98 | $13K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,030 | 12 | $38.26 | $39K |
| 99232 Hospital E&M - Subsequent | Facility | 203 | 45 | $62.88 | $13K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 179 | 15 | $0.24 | $42.11 |
| 99214 Office E&M - Established | Office | 72 | 47 | $91.20 | $6,566 |
| 96365 Intravenous Infusion, Hydration | Office | 61 | 48 | $52.54 | $3,205 |
| 99215 Office E&M - Established | Office | 42 | 31 | $138.22 | $5,805 |
| 96366 Intravenous Infusion, Hydration | Office | 25 | 13 | $17.03 | $426 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 23 | 16 | $13.31 | $306 |
| 99205 Office E&M - New | Office | 22 | 22 | $166.56 | $3,664 |
| 99443 Telephone Services | Office | 20 | 15 | $92.00 | $1,840 |
| 96372 Injection Administration | Office | 19 | 15 | $11.92 | $226 |
| 96375 Injection Administration | Office | 16 | 16 | $12.82 | $205 |
| 96413 Chemotherapy Administration | Office | 13 | 13 | $108.79 | $1,414 |
By year: 2022 $20K for 203 services; 2023 $124K for 7,952 services; 2024 $294K for 19,019 services.
Medicare prescription drug claims, 2024
In 2024, the drug Antoine N Saliba prescribed most often to Medicare patients was Acyclovir, with 77 prescriptions and refills. In total Antoine N Saliba wrote 555 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 77 | 114 | 19 | $949 |
| Hydroxyurea Generic | 63 | 119 | 13 | $2,263 |
| Jakafi Ruxolitinib Phosphate | 58 | 58 | Under 11 | $737K |
| Fluconazole Generic | 44 | 48 | 13 | $2,949 |
| Levofloxacin Generic | 32 | 32 | Under 11 | $479 |
| Venclexta Venetoclax | 27 | 27 | Under 11 | $82K |
| Cefdinir Generic | 24 | 24 | Under 11 | $1,156 |
| Idhifa Enasidenib Mesylate | 20 | 20 | Under 11 | $776K |
| Rosuvastatin Calcium Generic | 14 | 18 | Under 11 | $67.94 |
| Tasigna Nilotinib Hcl | 13 | 13 | Under 11 | $67K |
| Bosulif Bosutinib | 11 | 11 | Under 11 | $135K |
Brand drugs: 166 claims; generic drugs: 389 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Antoine N Saliba $2,300 ($2,300 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,650.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.